WNT3a Signaling Inhibits Aromatase Expression in Breast Adipose Fibroblasts-A Possible Mechanism Supporting the Loss of Estrogen Responsiveness of Triple-Negative Breast Cancers

Int J Mol Sci. 2023 Feb 28;24(5):4654. doi: 10.3390/ijms24054654.

Abstract

Estrogen-dependent breast cancers rely on a constant supply of estrogens and expression of estrogen receptors. Local biosynthesis, by aromatase in breast adipose fibroblasts (BAFs), is their most important source for estrogens. Triple-negative breast cancers (TNBC) rely on other growth-promoting signals, including those from the Wnt pathway. In this study, we explored the hypothesis that Wnt signaling alters the proliferation of BAFs, and is involved in regulation of aromatase expression in BAFs. Conditioned medium (CM) from TNBC cells and WNT3a consistently increased BAF growth, and reduced aromatase activity up to 90%, by suppression of the aromatase promoter I.3/II region. Database searches identified three putative Wnt-responsive elements (WREs) in the aromatase promoter I.3/II. In luciferase reporter gene assays, promoter I.3/II activity was inhibited by overexpression of full-length T-cell factor (TCF)-4 in 3T3-L1 preadipocytes, which served as a model for BAFs. Full-length lymphoid enhancer-binding factor (LEF)-1 increased the transcriptional activity. However, TCF-4 binding to WRE1 in the aromatase promoter, was lost after WNT3a stimulation in immunoprecipitation-based in vitro DNA-binding assays, and in chromatin immunoprecipitation (ChIP). In vitro DNA-binding assays, ChIP, and Western blotting revealed a WNT3a-dependent switch of nuclear LEF-1 isoforms towards a truncated variant, whereas β-catenin levels remained unchanged. This LEF-1 variant revealed dominant negative properties, and most likely recruited enzymes involved in heterochromatin formation. In addition, WNT3a induced the replacement of TCF-4 by the truncated LEF-1 variant, on WRE1 of the aromatase promoter I.3/II. The mechanism described here may be responsible for the loss of aromatase expression predominantly associated with TNBC. Tumors with (strong) expression of Wnt ligands actively suppress aromatase expression in BAFs. Consequently a reduced estrogen supply could favor the growth of estrogen-independent tumor cells, which consequently would make estrogen receptors dispensable. In summary, canonical Wnt signaling within (cancerous) breast tissue may be a major factor controlling local estrogen synthesis and action.

Keywords: LEF-1 (lymphoid enhancer binding factor 1); TCF-4 (T-cell factor 4); Wnt signaling; aromatase; breast adipose fibroblast; breast cancer; gene regulation; β-catenin.

MeSH terms

  • Adipose Tissue* / metabolism
  • Aromatase* / genetics
  • Aromatase* / metabolism
  • DNA / chemistry
  • Estrogens / metabolism
  • Fibroblasts / metabolism
  • Humans
  • Receptors, Estrogen / metabolism
  • Triple Negative Breast Neoplasms* / metabolism
  • Wnt3A Protein* / metabolism
  • beta Catenin / metabolism

Substances

  • Aromatase
  • beta Catenin
  • DNA
  • Estrogens
  • Receptors, Estrogen
  • Wnt3A Protein
  • WNT3A protein, human

Grants and funding

This research was supported by an educational grant to A.K. from the Richard-Winter-Stiftung, Stuttgart (no grant number). We acknowledge support by the German Research Foundation Projekt-Nr. 512648189 and the Open Access Publication Fund of the Thueringer Universitaets-und Landesbibliothek Jena.